Lori Sakoda to Body Mass Index
This is a "connection" page, showing publications Lori Sakoda has written about Body Mass Index.
Connection Strength
0.304
-
Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants. J Natl Cancer Inst. 2021 01 04; 113(1):38-47.
Score: 0.139
-
Body mass index and molecular subtypes of colorectal cancer. J Natl Cancer Inst. 2023 Feb 08; 115(2):165-173.
Score: 0.040
-
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. BMC Med. 2020 12 17; 18(1):396.
Score: 0.035
-
Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk. Cancer Med. 2020 05; 9(10):3563-3573.
Score: 0.033
-
Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Carcinogenesis. 2010 May; 31(5):842-6.
Score: 0.016
-
Variants in hormone-related genes and the risk of biliary tract cancers and stones: a population-based study in China. Carcinogenesis. 2009 Apr; 30(4):606-14.
Score: 0.015
-
Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007 09; 86(3):s843-57.
Score: 0.014
-
CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China. Int J Cancer. 2006 Jun 01; 118(11):2847-53.
Score: 0.013